5-FU Toxicity and DPD: A New Option to Treat Pyrimidine Analogue Overdose
September 21st 20175-Fluorouracil is the mainstay of treatment for many cancers, with upwards of 30% rates of adverse effects. DPD deficiency can further amplify these effects and even lead to life-threatening toxicity. Uridine triacetate is FDA approved for 5-FU and capecitabine overdose treatment within 96 hours of administration.
Read More
FDA Approves First Once-Daily Single Inhaler Triple Therapy for COPD
September 19th 2017Officials with the FDA have approved fluticasone furoate/umeclidinium/vilanterol (FF/UMEC/VI) (Trelegy Ellipta, GlaxoSmithKline and Innoviva), for the maintenance treatment of patients with chronic obstructive pulmonary disease (COPD).
Read More